Chad F. Phipps - Mar 17, 2023 Form 4 Insider Report for ZIMMER BIOMET HOLDINGS, INC. (ZBH)

Role
Sr. VP/Gen Counsel/Secretary
Signature
/s/ Matthew R. St. Louis, Attorney-in-Fact for Chad F. Phipps (power of attorney previously filed)
Stock symbol
ZBH
Transactions as of
Mar 17, 2023
Transactions value $
-$1,233,609
Form type
4
Date filed
3/21/2023, 04:03 PM
Previous filing
Mar 8, 2023
Next filing
Feb 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZBH Common Stock Options Exercise $1.64M +23K +52.77% $70.97 66.7K Mar 17, 2023 Direct F1
transaction ZBH Common Stock Sale -$2.46M -19.7K -29.59% $124.40 47K Mar 17, 2023 Direct F1, F2
transaction ZBH Common Stock Sale -$413K -3.3K -7.03% $125.09 43.7K Mar 17, 2023 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZBH Employee Stock Option (right to buy) Options Exercise $0 -23K -100% $0.00* 0 Mar 17, 2023 Common Stock 23K $70.97 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on November 29, 2022.
F2 Reflects the weighted average price of 19,743 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $123.85 to $124.84 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.
F3 Reflects the weighted average price of 3,302 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2023 with sale prices ranging from $124.87 to $125.38 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price.
F4 Vested annually over four years in increments of 25% each year, commencing on March 18, 2014.